Midostaurin for FLT3-mutated Acute Myeloid Leukaemia – Considerations for Optimal Use

European Oncology and Haematology · Published 2019-01-01 · DOI 10.17925/eoh.2019.15.1.43

Authors being retrieved — see the publisher record. https://doi.org/10.17925/eoh.2019.15.1.43

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2019

Related articles